Pharmaceutical Industry Today

External Urine Management Products Market Poised for Steady Growth, Projected to Reach USD 940.76 Million by 2032

The external urine management products market is experiencing consistent growth driven by infection prevention priorities and patient-centric care models. Technological innovation, expanding home care adoption, and strong regional demand position the market for sustained expansion through 2032.
Published 17 December 2025

The global External Urine Management Products market was valued at USD 632.26 million in 2024 and is expected to reach USD 940.76 million by 2032, expanding at a CAGR of 5.11% over the 2025–2032 forecast period. Market growth is being fueled by increasing awareness of catheter-associated urinary tract infection (CAUTI) prevention, rising geriatric populations, and growing adoption of non-invasive urinary management solutions across hospitals and home care settings.

External urine management products are increasingly preferred due to their ability to improve patient comfort, reduce infection risks, and lower overall healthcare costs. Technological advancements in adhesive materials, moisture control, and gender-specific designs are further accelerating adoption across diverse care environments, particularly in long-term care and home-based treatment models.

Get free Sample Report@ https://www.snsinsider.com/sample-request/7941

Market Dynamics and Growth Drivers

The market is witnessing sustained momentum as healthcare systems globally prioritize patient safety and infection control. External urine management solutions offer a clinically proven alternative to indwelling catheters, supporting better outcomes and shorter hospital stays. Additionally, the shift toward patient-centric care and remote monitoring is expanding demand in non-hospital settings, especially among elderly and mobility-impaired populations.

Segmentation Analysis

By Product

Male external catheters dominated the market in 2024, accounting for over 65.12% of total revenue. Their widespread adoption is supported by long-standing clinical use, ease of application, improved urine containment, and strong evidence in reducing CAUTIs. Continuous innovation in skin-safe adhesives and moisture management technologies has further strengthened demand.

The female external catheter segment is expected to register the fastest growth during the forecast period. Increasing focus on gender-inclusive healthcare, improved anatomical fit, enhanced skin barriers, and vacuum-assisted collection systems are addressing historical challenges related to leakage and comfort, driving rapid adoption.

By Distribution Channel

Offline distribution channels accounted for more than 57.25% of global revenue in 2024. Hospitals, clinics, and medical supply stores continue to rely on offline procurement for bulk purchasing, immediate availability, and quality verification, supported by institutional contracts and professional guidance.

Online distribution is the fastest-growing channel, driven by expanding e-commerce platforms, subscription-based models, and doorstep delivery services. These channels are gaining traction among home care patients and caregivers seeking convenience, affordability, and broader product access.

By End Use

Hospitals held over 45.7% market share in 2024, supported by high patient inflow, established CAUTI prevention protocols, and trained clinical staff. Hospitals remain central to product validation and clinical adoption.

Home care is projected to be the fastest-growing end-use segment, driven by aging populations, preference for home-based treatment, and rising demand for non-invasive, easy-to-use urinary management solutions integrated with caregiver education and telehealth services.

Regional Analysis

North America led the global market with over 43.2% revenue share in 2024, supported by advanced healthcare infrastructure, strong infection control practices, and high adoption of urological care solutions.

The U.S. market was valued at USD 206.38 million in 2024 and is projected to reach USD 272.17 million by 2032, growing at a CAGR of 3.57%. Growth is supported by widespread CAUTI prevention initiatives, favorable reimbursement frameworks, and significant R&D investments by leading manufacturers. Canada continues to contribute through rising geriatric populations and home-based care adoption, while Mexico benefits from expanding distribution networks and public healthcare spending.

Europe is the second-fastest-growing region, driven by aging demographics, increasing prevalence of urinary incontinence, and supportive reimbursement policies. Germany and the UK are key markets, supported by strong clinical protocols and expanding home care initiatives, while France and Spain are experiencing rising caregiver adoption.

Asia Pacific is expected to be the fastest-growing region over the forecast period. Growth is supported by increasing healthcare expenditures, improving awareness, and rapidly aging populations in China, India, and Japan. Government support for elderly care and home-based treatment models in countries such as South Korea and Australia further contributes to regional expansion.

Competitive Landscape

Key players operating in the global external urine management products market include Cardinal Health, Coloplast Corp., Hollister Inc., BD (C. R. Bard), Teleflex Inc., B. Braun Melsungen AG, Consure Medical, Men’s Liberty (BioDerm), Sage Products (Stryker), and Boehringer Laboratories LLC. These companies are actively investing in product innovation, strategic partnerships, and geographic expansion to strengthen their market presence.

Buy Full Report Now: https://www.snsinsider.com/checkout/7941

Recent Developments

  • In 2024, leading manufacturers reported increased adoption of advanced male external catheter systems, contributing to over 65% product share globally.
  • Investments in female-specific external catheter designs increased by more than 20% year-over-year, supporting higher forecasted growth in this segment.
  • North America accounted for over 43% of global revenue in 2024, reflecting strong institutional adoption and reimbursement support.
  • Asia Pacific healthcare spending growth exceeded 8% annually in key markets, accelerating demand for non-invasive urinary management solutions.

Other Trending Reports

Biochips Market

Behavioral Health Market

Immunohistochemistry Market

Pediatric Hospitals Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Rohan Jadhav - Principal Consultant

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Email: info@snsinsider.com

Other Industry News

Ready to start publishing

Sign Up today!